Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Vertical Research Downgrades Huntsman to Hold

Vertical Research Downgrades Huntsman to Hold

Vertical Research analyst Kevin McCarthy downgrades Huntsman (NYSE:HUN) from Buy to Hold.

February 22, 2023

1 minute read

Vertical Research analyst Kevin McCarthy downgrades Huntsman (NYSE:HUN) from Buy to Hold.

‘Tesla Already Planning Huge Giga Texas Expansion: Permits Filed’ – InsideEVs

July 1, 10:32 AM

https://insideevs.com/news/595647/tesla-gigafactory-texas-massive-expansion-permits/amp/

August 22, 6:05 AM

HC Wainwright & Co. analyst Patrick Trucchio maintains Freeline Therapeutics (NASDAQ:FRLN) with a Buy and lowers the price target from $20 to $15.

December 5, 12:00 PM

In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors…

October 24, 5:29 PM

-Reuters